VEGFA and preeclampsia: The results suggest that VDR activation by VD supplementation upregulates the expression of its downstream target gene VEGF and reduces the risk of adverse outcomes, such as gestational hypertension, preeclampsia, and offspring preterm delivery caused by maternal VD deficiency during pregnancy.